Results 131 to 140 of about 13,568 (181)
Some of the next articles are maybe not open access.

The epidemiology of polymyositis

The American Journal of Medicine, 1970
Incidence data and the descriptive epidemiology of polymyositis in a defined population area are reported. An age-adjusted incidence rate for hospital-diagnosed polymyositis of 5.0 cases per million population per year, over a twenty-two year period, for a racially mixed population, has been determined.
T A, Medsger, W N, Dawson, A T, Masi
openaire   +2 more sources

Eosinophilic polymyositis

Annals of Neurology, 1977
AbstractIn 3 patients with subacute polymyositis, muscle biopsies were remarkable for showing abundant infiltration by eosinophils. In each case the inflammatory myopathy was part of a systemic illness known as the hypereosinophilic syndrome (HES). The systemic manifestations included eosinophilia, anemia, hypergammaglobulinemia, vascular involvement ...
R B, Layzer, M A, Shearn, S, Satya-Murti
openaire   +3 more sources

POLYMYOSITIS AND TOXOPLASMOSIS

Acta Pathologica Japonica, 1981
Extensive severe polymyositis in a patient with toxoplasmosis was presented. Toxoplasmosis was serologically substantiated by a serial two‐tube rise in a toxoplasma‐antibody titer by a hemagglutination test. What appeared to be toxoplasma gondii was detected in areas of myositis.
T, Karasawa   +5 more
openaire   +2 more sources

Polymyositis and Penicillamine

Archives of Neurology, 1972
A 23-year-old asymptomatic woman, known to be homozygous for Wilson's disease, developed polymyositis while receiving prophylactic penicillamine. Symptoms abated when penicillamine was discontinued. Possible effects of penicillamine on immune mechanisms are discussed. The symptoms of Wilson's disease and polymyositis may be difficult to differentiate.
P L, Schraeder, H A, Peters, D S, Dahl
openaire   +2 more sources

Cervicobrachial Polymyositis

Journal of Clinical Neuromuscular Disease, 2014
To characterize and analyze a subgroup of patients with polymyositis presented with predominant or isolated proximal upper limb and neck weakness.Patients with polymyositis, presenting with predominant or isolated weakness of upper limbs and the neck, were included. Bohan and Peter and Targoff criteria were used for the diagnosis of polymyositis.
Satish V, Khadilkar   +2 more
openaire   +2 more sources

Polymyositis and dermatomyositis

The Lancet, 2003
The inflammatory myopathies, commonly described as idiopathic, are the largest group of acquired and potentially treatable myopathies. On the basis of unique clinical, histopathological, immunological, and demographic features, they can be differentiated into three major and distinct subsets: dermatomyositis, polymyositis, and inclusion-body myositis ...
Dalakas, M., Hohlfeld, R.
openaire   +3 more sources

Dermatomyositis and polymyositis

Current Treatment Options in Neurology, 2003
Dermatomyositis (DM) and polymyositis (PM) are idiopathic inflammatory myopathies characterized by proximal greater than distal muscle weakness, elevated serum creatine kinase levels, electrophysiologic abnormalities, and inflammation on muscle biopsy.
Hannah R., Briemberg, Anthony A., Amato
openaire   +2 more sources

Polymyositis

Neurology, 2008
Within the neuromuscular community, few issues have generated more discussion and controversy than the classification, diagnostic criteria, and prevalence of the idiopathic inflammatory myopathies (IIM). For over a century after its initial description, the term polymyositis (PM) was applied loosely to any condition characterized by weakness and ...
Georgina Espígol, Josep M. Grau
openaire   +2 more sources

Polymyositis

Southern Medical Journal, 1976
A 70-year-old woman with polymyositis was treated with three different immunosuppressive drugs. Her condition deteriorated over a three-month period until she became totally helpness. She then made a dramatic improvement when large doses of vitamin E (d, alpha-tocopheryl acetate) were administered. Current knowledge regarding the nature of polymyositis
R N, Killeen, S, Ayres, R, Mihan
openaire   +2 more sources

AUTOANTIBODIES IN POLYMYOSITIS

Rheumatic Disease Clinics of North America, 1992
A group of autoantibodies have been identified that are found almost exclusively in patients with polymyositis and dermatomyositis (myositis-specific antibodies). Most have been associated with characteristic clinical subgroups. Five of the myositis-specific antibodies are directed at aminoacyl-tRNA synthetases and have been associated with a similar ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy